Abstract | BACKGROUND: Vascular embolism is a serious complication of hyaluronic acid (HA) filler cosmetic injection, and hyaluronidase injection has been proposed as the treatment. Until now, there has been a lack of adequate clinical evidence regarding the benefits of treatment for HA filler-induced vascular embolism by percutaneous facial or supratrochlear arterial hyaluronidase injection. OBJECTIVES: The authors sough to evaluate the efficacy of percutaneous facial or supratrochlear arterial hyaluronidase injection as a rescue treatment for HA filler-induced vascular embolism. METHODS: RESULTS: After hyaluronidase injection, facial skin necrosis in all cases was restored and ptosis in the 4 cases was also significantly relieved. Patients were subsequently followed-up for 1 month to 1 year. The skin necrosis in 16 patients completely healed, and only 1 patient had small superficial scars. CONCLUSIONS: It is effective to alleviate skin necrosis and ptosis resulting from HA filler embolism via percutaneous facial or supratrochlear arterial hyaluronidase injection. LEVEL OF EVIDENCE: 4:
|
Authors | Can Zheng, Qiang Fu, Gui-Wen Zhou, Lin-Ying Lai, Li-Xia Zhang, De-Quan Zhang, Guo-Jie Chen, Li-Ming Liang, Min-Liang Chen |
Journal | Aesthetic surgery journal
(Aesthet Surg J)
Vol. 42
Issue 6
Pg. 649-655
(05 18 2022)
ISSN: 1527-330X [Electronic] England |
PMID | 34958671
(Publication Type: Journal Article)
|
Copyright | © The Author(s) 2021. Published by Oxford University Press on behalf of The Aesthetic Society. All rights reserved. For permissions, please e-mail: [email protected]. |
Chemical References |
- Dermal Fillers
- Hyaluronic Acid
- Hyaluronoglucosaminidase
|
Topics |
- Arteries
- Cosmetic Techniques
(adverse effects)
- Dermal Fillers
- Embolism
(drug therapy, etiology)
- Humans
- Hyaluronic Acid
- Hyaluronoglucosaminidase
- Injections, Intra-Arterial
- Necrosis
|